4583 — Chiome Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Chiome Bioscience, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,466 | -1,238 | -1,215 | -1,018 | -980 |
| Depreciation | |||||
| Non-Cash Items | 150 | — | — | -28 | — |
| Unusual Items | |||||
| Changes in Working Capital | 182 | 45.4 | 145 | 43.7 | 39.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,131 | -1,191 | -1,069 | -1,001 | -936 |
| Capital Expenditures | — | — | — | — | -40.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -35.4 | — | 0.173 | — | -15.4 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -35.4 | — | 0.173 | — | -55.5 |
| Financing Cash Flow Items | 0.001 | -0.001 | 0.001 | -0.583 | -7.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 271 | 1,127 | 667 | 1,738 | 133 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -895 | -63.7 | -402 | 738 | -858 |